Qube Research & Technologies Ltd - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,310,448
-62.6%
114,250
-17.6%
0.00%
-76.9%
Q2 2023$3,507,890
+105.4%
138,597
+161.4%
0.01%
+85.7%
Q1 2023$1,707,806
-34.8%
53,021
-62.6%
0.01%
-50.0%
Q4 2022$2,619,105
+238.4%
141,880
+394.9%
0.01%
+180.0%
Q3 2022$774,000
+11.4%
28,669
+22.3%
0.01%
-37.5%
Q2 2021$695,000
+92.5%
23,435
+63.3%
0.01%
+60.0%
Q3 2020$361,000
+12.8%
14,353
+9.4%
0.01%0.0%
Q2 2020$320,00013,1170.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,405,039$118,936,0009.40%
Essex Woodlands Management, Inc. 457,085$12,341,0005.10%
Evolutionary Tree Capital Management, LLC 191,868$5,180,0004.98%
Ghost Tree Capital, LLC 390,000$10,530,0002.96%
Antara Capital LP 4,069,400$109,874,0002.90%
RICE HALL JAMES & ASSOCIATES, LLC 896,754$24,212,0001.40%
Jericho Capital Asset Management L.P. 714,000$19,278,0001.22%
Antara Capital LP 1,600,000$43,200,0001.14%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 120,000$3,240,0001.04%
TANG CAPITAL MANAGEMENT LLC 287,500$7,763,0000.95%
View complete list of REVANCE THERAPEUTICS INC shareholders